Atopic Dermatitis

Looking at atopic dermatitis treatment options

July 24, 2020

Atopic dermatitis treatment has dramatically changed over the years. Here’s a look at the current options.

FDA approves dupilumab for atopic dermatitis treatment in pediatrics

May 26, 2020

The US Food and Drug Administration has approved dupilumab (Dupixent, Sanofi and Regeneron) for the treatment of moderate-to-severe atopic dermatitis in children aged 6 to 11 years.

Postpartum depression linked to atopic dermatitis in children

February 06, 2020

Postpartum depression has a number of profound effects. A new study indicates that postpartum depression could increase the risk of atopic dermatitis, especially at ages 5 and 9 years.